The ROAM Research Study Therapy (LTOT) Version
The Respiratory Oxygen Adherence Monitor System for COPD With Long Term Oxygen Therapy
Who can join
All ages · All sexes
Full eligibility criteria
Inclusion Criteria: Post-Bronchodilator FEV1/FVC \<.80 * Race demographics of the recruitment area reflect the population of the Charlottesville Metropolitan Statistical Area (MSA). * Due to underrepresentation in local demographics, special effort (via targeted advertising) will be made to recruit Hispanic participants to better match national percentages. * Participants with medical history of COPD * Subjects has to have a prescription for oxygen use via nasal cannula or mask at home * At baseline of health with no hospitalization/exacerbation within the past 6 weeks * Use of Continuous oxygen at baseline Exclusion Criteria: Post -Bronchodilator FEV1 \< 25% * Intermittent oxygen use at home * Inability to understand simple instructions * No respiratory infections and exacerbation within 6 weeks of study
About the study
The purpose of this research is to test a device being developed that can see how patients use oxygen therapy over a long period of time. This study will focus on developing a new display part called ROAM module which will be attached to your oxygen source. The display will provide easily-accessible information that can show how you interact with your supplies and the oxygen machine automatically without connecting the oxygen source to the internet or other devices.
Sponsor: University of Virginia · Participants: 100 · Started: Jan 14, 2025
Contact the study team
- Roselove NUNOO-ASARE, MA · Phone: 434-243-6074
Official record on ClinicalTrials.gov — NCT06810323
Locations in the U.S.
| Virginia | University of Virginia, Charlottesville |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.